Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeneDx Holdings (WGS) Change in Cash: 2019-2024

Historic Change in Cash for GeneDx Holdings (WGS) over the last 6 years, with Dec 2024 value amounting to -$14.5 million.

  • GeneDx Holdings' Change in Cash rose 1101.76% to $21.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $38.1 million, marking a year-over-year increase of 229.49%. This contributed to the annual value of -$14.5 million for FY2024, which is 61.56% up from last year.
  • GeneDx Holdings' Change in Cash amounted to -$14.5 million in FY2024, which was up 61.56% from -$37.6 million recorded in FY2023.
  • In the past 5 years, GeneDx Holdings' Change in Cash registered a high of $282.5 million during FY2021, and its lowest value of -$263.2 million during FY2022.
  • In the last 3 years, GeneDx Holdings' Change in Cash had a median value of -$37.6 million in 2023 and averaged -$105.1 million.
  • Per our database at Business Quant, GeneDx Holdings' Change in Cash skyrocketed by 7,044.89% in 2021 and then plummeted by 193.15% in 2022.
  • Yearly analysis of 5 years shows GeneDx Holdings' Change in Cash stood at $4.0 million in 2020, then soared by 7,044.89% to $282.5 million in 2021, then slumped by 193.15% to -$263.2 million in 2022, then soared by 85.70% to -$37.6 million in 2023, then surged by 61.56% to -$14.5 million in 2024.